Archive page of posts in this category or categories:

The following posts are in no particular order. They are purposely randomized.

RSI News

QuarterWatch analyzes MedWatch Reports

This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs for psoriasis, a common skin disorder affecting an estimated 7.5 million people. While corticosteroid and other topical drugs are sufficient for many cases, potent immunosuppressant drugs are used in increasing…
Read More
RSI News

Value of information

Risk Sciences International (RSI) investigators Greg Paoli, Shintaro Hagiwara and Daniel Krewski collaborated with investigators from the US Center for Computational Toxicology and Exposure (CCTE) on the development of an analytical framework to evaluate alternative chemical toxicity testing strategies, meeting a need identified by the US National Research Council in its 2009 report on Science and…
Read More
RSI News

Dr. Mattison chairs NAM report

Compounded medications prepared by pharmacists or physicians have been used extensively throughout history as a mainstay of therapeutics.  Over the past half-century – with the increasing focus on evidence based treatment the use of compounded medications substantially decreased.  However, in some therapeutic areas, such as menopause, use of compounded medications continues.  The continuation of use…
Read More
RSI News

RSI Helps Strengthen Food Safety Culture in Vietnam

In mid-October 2025, Vietnamese and Canadian experts convened in Đà Nẵng to exchange approaches for strengthening food safety through risk science. The workshop brought together officials from Vietnam’s ministries and the Vietnam Food Safety Risk Assessment Center (VFSA), alongside the Canadian Food Inspection Agency (CFIA), under the umbrella of the SAFEGRO project—an initiative funded by…
Read More